MedTrace Logo

Evaluation of Eye Health Benefits of Blueberry Chewable Tablets

NCT04348110 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2021-01-15

No results posted yet for this study

Summary

To assess the efficacy of blueberry chewable tablets on Eye Health

Conditions

  • Eye

Interventions

DIETARY_SUPPLEMENT

Placebo tablets

consume 2 tablets per day for 8 weeks

DIETARY_SUPPLEMENT

Blueberry Chewable Tablets

consume 2 tablets per day for 8 weeks

Sponsors & Collaborators

  • TCI Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Bo-Yie Chen · Chung Shan Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-17
Primary Completion
2020-07-15
Completion
2020-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04348110 on ClinicalTrials.gov